Medunik USA

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Medunik USA is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Medunik USA

Medunik USA is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by SODIUM PHENYLBUTYRATE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: acute hyperammonemia, indicated adjunctive, therapy standard, includes dietary, chronic management, pediatric patients, urea cycle, disorders ucds. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
SODIUM PHENYLBUTYRATE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Medunik USA

Brand nameGenericTypeRoute
PHEBURANE SODIUM PHENYLBUTYRATE HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Medunik USA make?
1 FDA drug label records name Medunik USA as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Medunik USA produce?
The most frequent active ingredients in this portfolio are SODIUM PHENYLBUTYRATE.

Are Medunik USA products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.